.png)
Psychedelic Therapy Frontiers
The psychedelic renaissance is here! Join Dr. Steve Thayer, Dr. Reid Robison, and special guests as they explore the frontiers of psychedelic medicine and what it takes to cultivate a healthy mind, body, and spirit. Our hosts draw from their extensive knowledge and experience with psychedelic therapy research and treatment to discuss the science, practice, and art of psychedelic healing. If you are a helping professional, therapist, clinician, guide, healer, psychedelic enthusiast, or simply curious about mental, physical, and spiritual health, this is the podcast for you!
Psychedelic Therapy Frontiers
FDA rejects MAPS/Lykos MDMA therapy for PTSD
On Aug 9th the FDA rejected the new drug application by Lykos (formerly MAPS PBC) for MDMA-assisted therapy for PTSD. This is disappointing news for those of us who were excited about the promising study results and eager to add MDMA-assisted therapy to the menu of treatment options for those suffering with PTSD. We discuss what appears to have influenced the FDA’s decision, the possible path forward for Lykos, how this ruling affects other companies trying to bring different psychedelic medicines to market, and much more.
Learn more about our podcast at https://numinus.com/podcast/
Learn more about psychedelic therapy training opportunities at https://numinus.com/training/
Learn more about our clinical trials at https://www.numinus.com/clinical-trials
Learn more about Numinus at https://numinus.com/
Email us at ptfpodcast@numinus.com
Follow us on Instagram:
https://www.instagram.com/drstevethayer/
https://www.instagram.com/innerspacedoctor/
https://www.instagram.com/numinushealth/